| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |